137 related articles for article (PubMed ID: 4424774)
1. Adoptive immunotherapy in BALB-c times DBA-2 Cr F1 mice bearing an immunogenic subline of L1210 leukemia.
Nicolin A; Canti G; Goldin A
Cancer Res; 1974 Nov; 34(11):3044-8. PubMed ID: 4424774
[No Abstract] [Full Text] [Related]
2. Cell-mediated response to a mouse leukemic subline antigenically altered following drug treatment in vivo.
Nicolin A; Bini A; Franco P; Goldin A
Cancer Chemother Rep; 1974; 58(3):325-30. PubMed ID: 4841716
[No Abstract] [Full Text] [Related]
3. L1210 leukemia regression in non-immunosuppressed mice with therapeutic transfer of immune spleen cells--therapeutic adoptive transfer against L1210 leukemia.
Kawashima K; Nagura E; Nagase F; Kumazawa T; Nakashima I; Yamada K
Nihon Ketsueki Gakkai Zasshi; 1987 Sep; 50(6):1174-82. PubMed ID: 3687342
[No Abstract] [Full Text] [Related]
4. Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.
Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
Cancer Res; 1977 Apr; 37(4):964-8. PubMed ID: 403001
[TBL] [Abstract][Full Text] [Related]
5. Adoptive immunotherapy against a local or widespread tumor of a highly malignant and poorly immunogenic mouse leukemia L1210.
Naguma E; Kawashima K; Nagase F; Nakashima I; Ohno R; Yamada K
Nihon Ketsueki Gakkai Zasshi; 1986 Sep; 49(6):1212-21. PubMed ID: 3492848
[No Abstract] [Full Text] [Related]
6. Antigenic changes of L1210 leukemia in mice treated with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide.
Bonmassar E; Bonmassar A; Vadlamudi S; Goldin A
Cancer Res; 1972 Jul; 32(7):1446-50. PubMed ID: 4402275
[No Abstract] [Full Text] [Related]
7. Potentiation of concanavalin A-bound L1210 vaccine in vivo by chemotherapeutic agents.
Kataoka T; Kobayashi H; Sakurai Y
Cancer Res; 1978 May; 38(5):1202-7. PubMed ID: 639053
[No Abstract] [Full Text] [Related]
8. The effects of passive immunization with tumor-specific antiserum on the active immune response of mice to sublines of leukemia L1210.
Carlson GA; Terres G
J Immunol; 1978 Nov; 121(5):1752-9. PubMed ID: 712064
[TBL] [Abstract][Full Text] [Related]
9. Enhanced induction of immune resistance by concanavalin A-bound L1210 vaccine and an immunopotentiator prepared from Coriolus versicolor.
Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
Cancer Res; 1977 Dec; 37(12):4416-9. PubMed ID: 922733
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice.
Mihich E
Cancer Res; 1969 Apr; 29(4):848-54. PubMed ID: 4887203
[No Abstract] [Full Text] [Related]
11. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
12. Vaccination of leukemic mice with viable drug-altered leukemic cells.
Boerio D; Cavalli M; Marelli O; Veronese F; Nicolin A
Ric Clin Lab; 1978; 8(3):127-33. PubMed ID: 746293
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of preirradiation on adoptive antibody responses in DBA/2 and BALB/c mice.
Yonkosky D; Buffett RF; Bennett M
Radiat Res; 1978 Mar; 73(3):521-34. PubMed ID: 305575
[No Abstract] [Full Text] [Related]
14. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
Fuji H
Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
[TBL] [Abstract][Full Text] [Related]
15. Effect of low phenylalanine diet on murine leukemia L1210.
Pine MJ
J Natl Cancer Inst; 1978 Mar; 60(3):633-41. PubMed ID: 625067
[No Abstract] [Full Text] [Related]
16. Chemical and biological adjuvants capable of potentiating tumor cell vaccine.
Chirigos MA; Stylos WA; Schultz RM; Fullen JR
Cancer Res; 1978 Apr; 38(4):1085-91. PubMed ID: 416906
[TBL] [Abstract][Full Text] [Related]
17. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
BasombrÃo MA; Prehn RT
Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
[No Abstract] [Full Text] [Related]
18. Chemotherapeutic, carcinogenic, and cell-regulatory effects of triazenes.
Schmid FA; Hutchison DJ
Cancer Res; 1974 Jul; 34(7):1671-5. PubMed ID: 4833916
[No Abstract] [Full Text] [Related]
19. Rapid in vivo destruction of semi-syngeneic and allogeneic cells by nonimmunized mice as a consequence of nonidentity at H-2.
Carlson GA; Wegmann TG
J Immunol; 1977 Jun; 118(6):2130-7. PubMed ID: 864255
[No Abstract] [Full Text] [Related]
20. Acceleration of allogeneic antitumor immunity with immune RNA in vitro and T-cell suppression by L1210 tumor bearer spleen cells.
Miura T; Maekawa T; Kurashige S; Mitsuhashi S
Cancer Res; 1981 Feb; 41(2):383-98. PubMed ID: 6160907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
